BE807753A - Composition steroidique pour l'application topique et son utilisation - Google Patents

Composition steroidique pour l'application topique et son utilisation

Info

Publication number
BE807753A
BE807753A BE138125A BE138125A BE807753A BE 807753 A BE807753 A BE 807753A BE 138125 A BE138125 A BE 138125A BE 138125 A BE138125 A BE 138125A BE 807753 A BE807753 A BE 807753A
Authority
BE
Belgium
Prior art keywords
topical application
steroid composition
steroid
composition
topical
Prior art date
Application number
BE138125A
Other languages
English (en)
Inventor
L T Difazio
M A Augustine
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of BE807753A publication Critical patent/BE807753A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
BE138125A 1972-11-24 1973-11-23 Composition steroidique pour l'application topique et son utilisation BE807753A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US309295A US3892857A (en) 1972-11-24 1972-11-24 Steroid formulation

Publications (1)

Publication Number Publication Date
BE807753A true BE807753A (fr) 1974-05-24

Family

ID=23197591

Family Applications (1)

Application Number Title Priority Date Filing Date
BE138125A BE807753A (fr) 1972-11-24 1973-11-23 Composition steroidique pour l'application topique et son utilisation

Country Status (11)

Country Link
US (1) US3892857A (fr)
JP (1) JPS5726243B2 (fr)
BE (1) BE807753A (fr)
CA (1) CA1014469A (fr)
DE (1) DE2355710C2 (fr)
FR (1) FR2207692B1 (fr)
GB (1) GB1444989A (fr)
IE (1) IE39957B1 (fr)
NL (1) NL7315922A (fr)
PH (1) PH10338A (fr)
ZA (1) ZA738130B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US4048310A (en) * 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
US4065452A (en) * 1976-08-02 1977-12-27 Syntex (U.S.A.) Inc. 21,21-Dihalo steroids
DE2851544C2 (de) * 1978-11-29 1985-09-26 Beiersdorf Ag, 2000 Hamburg Fluocortolon-haltige Creme
AU5794680A (en) * 1979-05-31 1980-12-04 E.R. Squibb & Sons, Inc. Corticosteroid stick formulations
DE2964471D1 (en) * 1979-06-08 1983-02-17 Toko Yakuhin Kogyo Kk Creamy preparation containing steroid and process for the preparation thereof
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
DE3109459A1 (de) * 1981-03-09 1982-09-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen (delta)(pfeil hoch)9(pfeil hoch)(pfeil hoch)((pfeil hoch)(pfeil hoch)1(pfeil hoch)(pfeil hoch)1(pfeil hoch)(pfeil hoch))(pfeil hoch)- und (delta)(pfeil hoch)1(pfeil hoch)(pfeil hoch)6(pfeil hoch)-21-chlor-20-keto-steroide der pregnan- und d-homo-pregnan-reihe, verfahren zu ihrer herstellung und ihre verwendung als zwischenprodukte fuer die synthese von hochwirksamen corticoiden
US4344940A (en) * 1981-11-30 1982-08-17 E. R. Squibb & Sons, Inc. Steroid formulation containing dipotassium EDTA
US4914090A (en) * 1985-11-01 1990-04-03 Schering Corporation Ophthalmic compositions
JPH0735330B2 (ja) * 1986-03-12 1995-04-19 久光製薬株式会社 外用クリ−ム組成物
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US4868169A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid cream formulation
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
ATE162080T1 (de) * 1991-07-16 1998-01-15 Schering Ag Verfahren zur herstellung von mikronisierte wirkstoffe enthaltende halbfeste zubereitungen
EP0548088B1 (fr) * 1991-07-16 1998-01-14 Schering Aktiengesellschaft Procede de fabrication de preparations semi-solides renfermant une matiere active micronisee
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
US8796248B2 (en) * 2007-10-05 2014-08-05 Nektar Therapeutics Oligomer-corticosteroid conjugates
JP4891207B2 (ja) * 2007-11-27 2012-03-07 大洋香料株式会社 抗菌剤及びそれを含有する皮膚外用剤
FR3138377B1 (fr) 2022-07-26 2024-06-14 Psa Automobiles Sa Véhicule automobile comportant un système de restitution d’images du moteur thermique à l’utilisateur dudit véhicule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3694471A (en) * 1970-06-08 1972-09-26 Warner Lambert Pharmaceutical 17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides

Also Published As

Publication number Publication date
AU6165273A (en) 1975-04-24
IE39957B1 (en) 1979-02-14
JPS5726243B2 (fr) 1982-06-03
GB1444989A (en) 1976-08-04
JPS4981520A (fr) 1974-08-06
ZA738130B (en) 1974-08-28
CA1014469A (en) 1977-07-26
IE39957L (en) 1974-05-24
DE2355710C2 (de) 1985-04-25
NL7315922A (fr) 1974-05-28
PH10338A (en) 1976-12-09
DE2355710A1 (de) 1974-05-30
FR2207692A1 (fr) 1974-06-21
FR2207692B1 (fr) 1976-05-14
US3892857A (en) 1975-07-01

Similar Documents

Publication Publication Date Title
BE807753A (fr) Composition steroidique pour l'application topique et son utilisation
BE844539A (fr) Composition pour application locales et son utilisation
AU462120B2 (en) New sulphur-containing organo-organooxysilanes and their use
BE757004A (fr) Agent d'etancheite
BE864735Q (fr) Toile d'emballage pour emplatre pourvu du pansement
FR2282566A1 (fr) Raccords d'assemblage tournant
BE777306R (fr) Agents d'enduction
PH9532A (en) Trifluoromethylmercapto-acetamidocephalosporins and composition thereof
FR2342061A1 (fr) Formulations pour application topique de steroides
IT1005005B (it) Composizioni topiche contenenti vaselina e amido idro repellente e metodo per realizzarle
CH518097A (fr) Composition tinctoriale pour cheveux humains
CH514339A (fr) Composition tinctoriale pour cheveux humains
BE817755A (fr) 8-oxamorphinanes substitues en positions 3 et 14
CH542259A (fr) Composition durcissable à l'eau et son utilisation
BR7202228D0 (pt) Agente anti-inflamatorio
SE388802B (sv) Overforings- och sammansettningsanordning
IT1020149B (it) Dispositivo josephson
BE795744A (fr) Compositions retardatrices d'inflammation
BE814811R (nl) Hoofdverdeler en schakelinrichting
BE786996A (fr) Reducteur d'oedeme
FR1500730A (fr) Composition d'enduisage
CH543280A (fr) Composition tinctoriale pour cheveux humains
CH541588A (fr) Composition polymérisable et son utilisation
FR1521648A (fr) Composition pour moulage de précision et son mode d'utilisation
AU1628267A (en) New and improved cement composition

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: E.R. SQUIBB & SONS INC.

Effective date: 19931123